Chromatological and immunohistochemical study of oral premalignant lesions-Evaluation of mailgnant potentiality-
口腔癌前病变的色谱和免疫组织化学研究-恶性潜能评估-
基本信息
- 批准号:05671659
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Oral leukoplakia is known as a premalignant lesion. But every leukoplakia doesn't develop malignancy and it may not necessarily be easy to distinguish the leukoplakias with verious levels of malignant potentiality. The aim of this study was to find the effective measures to evaluate the malignant potentiality of leukoplakia objectively and quantitatively.1)As to clinical finding, the color of leukoplakia is closely connected with the malignant potentiality and the leukoplakia with red component has the higher risk. Accordingly the color of the lingual leukoplakia was measured with the new-type of colorimeter without touching the object. The measured color was recorded in figures and the color difference from the normal lingual color was expressed in CIE-LAB system, the three-dimentional standard coordinates (L^*a^*b^*). In general value index (L^*) is high and chromaticness index (a^*, b^*) is low in leukoplakia. But so far as leukoplakia with severe epithelial dyspasia is concerned, the peculiar color (L^* is low and a^*, b^* is high) namely red component made its appearance.2)Concerning histopathological finding, the cytokeratin (CK) expression pattern in oral epithelium is related to the cellular differentiation level. Therefore immunohistochemical analysis of CK expression was thought to be useful aid for the objective evaluation of dysplastic change in leukoplakias. CK10 expression was seen in the epithelium with hyperorthokeratosis and CK13 in the stratum spinosum of the leukoplakia with slight dysplasia. But both CK10 and CK13 were absent in areas with increased degree of cellular atypia. CK high molecular weight, whict includes CK 1,5,10,14, was expressed strongly in the areas where the rete ridge showed irregular elongation. Expression of CK19 was normally seen only in the stratum basale, but also in suprabasal cells in the leukoplakia with severe dysplasia.
口腔粘膜白斑病被称为癌前病变。但并不是所有的白斑都有恶变的可能,不同恶性程度的白斑也不一定容易鉴别。本研究的目的是寻找客观、定量评价白斑恶性潜能的有效方法。1)临床表现方面,白斑颜色与白斑恶性潜能密切相关,红色成分的白斑危险性较高。据此,用新型比色计对舌白斑进行了不接触物体的比色测定。将测得的颜色以数字的形式记录下来,并将与正常舌色的色差以CIE-LAB系统中的三维标准坐标(L^*a^*B^*)表示。一般白斑的明度指数(L^*)较高,色度指数(a^*,B^*)较低。但对于重度上皮发育不良的白斑,出现了特殊的颜色(L^* 低,a^*、B^* 高)即红色成分。2)组织病理学发现,口腔上皮细胞角蛋白(CK)的表达模式与细胞分化程度有关。因此,CK表达的免疫组化分析被认为是有用的援助,以客观评价白斑的不典型性改变。角化过度的上皮细胞中可见CK 10的表达,轻度异型增生的白斑棘层中可见CK 13的表达。而在细胞浸润程度增加的区域,CK 10和CK 13均缺失。CK高分子量蛋白(包括CK 1、5、10、14)在网脊呈不规则伸长的区域表达较强。CK 19的表达仅见于基底层,但在伴有重度异型增生的白斑中,CK 19的表达也见于基底层上细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJII Eiji其他文献
FUJII Eiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJII Eiji', 18)}}的其他基金
Market-government paradox under globalization: Analyzing consistency, comlementarity, and substitutability
全球化下的市场与政府悖论:分析一致性、互补性和可替代性
- 批准号:
25285087 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis on structural changes and imbalances of the world economy
世界经济结构变化与失衡分析
- 批准号:
20530263 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural shifts in monetary policy conduct, inflation environment, and exchange rate pass-through
货币政策行为、通胀环境和汇率传导的结构性转变
- 批准号:
17530205 - 财政年份:2005
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on behavioral dynamics of relative prices and retail market integration
相对价格行为动力学与零售市场一体化研究
- 批准号:
14530039 - 财政年份:2002
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Protein Phosphatase in Oral Colorectal Cancer
口腔结直肠癌蛋白磷酸酶分析
- 批准号:
07672159 - 财政年份:1995
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The microbiome associated with oral Leukoplakia: A multi-omics mechanistic study
与口腔白斑相关的微生物组:一项多组学机制研究
- 批准号:
10870268 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Detection of tumor cells with stem cell characteristics in oral leukoplakia
口腔白斑中具有干细胞特征的肿瘤细胞的检测
- 批准号:
237290448 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Research Grants
Gene expression analysis and applying carcinogenesis prediction in clinical setting for oral leukoplakia
口腔白斑的基因表达分析和致癌预测在临床中的应用
- 批准号:
23792323 - 财政年份:2012
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CLINICAL TRIAL: BOWMAN-BIRK INHIBITOR CONCENTRATE AND ORAL LEUKOPLAKIA: PHASE I
临床试验:BOWMAN-BIRK 抑制剂浓缩物和口腔白斑:第一阶段
- 批准号:
8166894 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Study on the mechanism of malignant transformation of oral leukoplakia mediated by p63 and Notch signaling pathway
p63和Notch信号通路介导的口腔白斑恶变机制研究
- 批准号:
20791531 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
BOWMAN-BIRK 抑制剂浓缩液
- 批准号:
7716696 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
CLINICAL TRIAL: BOWMAN-BIRK INHIBITOR CONCENTRATE AND ORAL LEUKOPLAKIA: PHASE I
临床试验:BOWMAN-BIRK 抑制剂浓缩物和口腔白斑:第一阶段
- 批准号:
7951026 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
BOWMAN-BIRK 抑制剂浓缩液
- 批准号:
7982106 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Occurrence mechanism of oral leukoplakia and squamous cell carcinoma examining from abnormality of stromal tissue
从基质组织异常看口腔白斑和鳞状细胞癌的发生机制
- 批准号:
19592314 - 财政年份:2007
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CLINICAL TRIAL: BOWMAN-BIRK INHIBITOR CONCENTRATE AND ORAL LEUKOPLAKIA: PHASE I
临床试验:BOWMAN-BIRK 抑制剂浓缩物和口腔白斑:第一阶段
- 批准号:
7724982 - 财政年份:2007
- 资助金额:
$ 1.28万 - 项目类别: